MCC950, a type of thiourea compound, is a specific inhibitor of NLRP3 and has been once administered to hypertensive kidney and renal fibrosis induced by oxalate crystallization animal models.45, 46. This evidence concerns the gene NLRP3 and renal fibrosis.